表紙:再生医療の世界市場
市場調査レポート
商品コード
1199199

再生医療の世界市場

Regenerative Medicine

出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 198 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.52円
再生医療の世界市場
出版日: 2023年01月01日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 198 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

世界の再生医療の市場規模は、COVID-19後のビジネス情勢の変化によって、2022年は96億米ドルと推定され、2022年から2030年にかけて15.8%のCAGRで成長し、2030年までに308億米ドルに達すると予測されています。

当レポートでは、世界の再生医療市場について調査分析し、市場の動向と促進要因、地域分析、競合情勢などの情報を提供しています。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他の欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP-1241

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Regenerative Medicine Market to Reach $30.8 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Regenerative Medicine estimated at US$9.6 Billion in the year 2022, is projected to reach a revised size of US$30.8 Billion by 2030, growing at a CAGR of 15.8% over the analysis period 2022-2030. Cell Therapy, one of the segments analyzed in the report, is projected to record a 16.3% CAGR and reach US$15.2 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Gene Therapy segment is readjusted to a revised 15.7% CAGR for the next 8-year period.

The U.S. Market is Estimated at $2.8 Billion, While China is Forecast to Grow at 14.7% CAGR

The Regenerative Medicine market in the U.S. is estimated at US$2.8 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$5.2 Billion by the year 2030 trailing a CAGR of 14.7% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 14.4% and 13.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 11.2% CAGR.

Select Competitors (Total 52 Featured):

  • AlloSource
  • Anika Therapeutics, Inc.
  • Bioventus LLC
  • DePuy Synthes Spine, Inc.
  • Exactech, Inc.
  • Integra LifeSciences Holdings Corp.
  • LifeNet Health, Inc.
  • Medtronic, PLC
  • NovaBone Products LLC
  • NuVasive, Inc.
  • Orthofix International N.V.
  • Osiris Therapeutics, Inc.
  • Smith & Nephew plc
  • Stryker Corporation
  • Wright Medical Technology, Inc.
  • Zimmer Biomet Holdings, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Regenerative Medicine: A Preface
    • Recent Market Activity
    • An Overview of Regenerative Medicine in Bone and Joint Applications
    • Current and Future Analysis
    • Developed Markets Dominate, Developing to Drive Growth
    • Regenerative Medicine - Past, Present & Future
    • Another Revolution in the Making?
    • Conventional Chemical Medicine Vs Regenerative Medicine
    • Regenerative Medicine - Bypassing the Ethical Concerns
    • Regenerative Medicine Throws Up Several New Therapies
    • Current Global Market for Regenerative Medicine
    • Market Potential
    • Therapeutic Companies and Products in Regenerative Medicine - Current Status
    • Regenerative Medicine - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
    • AlloSource (US)
    • Anika Therapeutics, Inc. (US)
    • Bioventus LLC (US)
    • DePuy Synthes Companies (US)
    • DePuy Synthes Spine, Inc. (US)
    • Exactech, Inc. (US)
    • Integra LifeSciences Holdings Corp. (US)
    • LifeNet Health, Inc. (US)
    • Medtronic, plc (Ireland)
    • NovaBone Products LLC (US)
    • NuVasive, Inc. (US)
    • Orthofix International N.V. (Netherlands)
    • Osiris Therapeutics, Inc. (US)
    • Smith & Nephew plc (UK)
    • Stryker Corporation (US)
    • Wright Medical Technology, Inc. (US)
    • Zimmer Biomet Holdings, Inc. (US)
  • 3. MARKET TRENDS & DRIVERS
    • A Combination of Factors to Drive Regenerative Medicine Market
    • Burgeoning Global Population Offers Significant Growth Opportunities
    • Aging Global Population: Need for New Effective Treatments
    • Increasing Healthcare Spending in Emerging Markets: Opportunities in Store
    • Government Support and Increased Private Sector Participation
    • Investment and Funding Landscape
    • Major M&A Activity and Strategic Alliances in Regenerative Medicine: 2011-2016
    • Recent Advancements in the Science of Regenerative Medicine
    • Advanced Ceramics Gaining Preeminence in Regenerative Medicine Field
    • 3D Organ & Tissue Printing: Still in Early Stages
    • Nanotechnology in Regenerative Medicine
    • Issues to be Sorted Out
    • Need for New Scientific and Technological Standards
    • Standardized Guidelines
    • Clinical Translation - Collaboration of Multidisciplinary Skills is Essential
    • The Question of Apt Business Models - The Service and Product Approach
    • Autologous or Service Approach Preferred by European Firms
    • Allogenic or Product Approach - Slow to Develop
    • Regenerative Medicine Requires Improved Biomaterials
    • Investors Wary of Funding Regenerative Medicine
    • Regenerative Medicine Field Lags Behind Due to Segregated Focus
    • Challenges Encountered by Regenerative Medicine
    • Scientific and Technological Challenges
    • Barriers in Sharing Intellectual Property Rights
    • Viable Manufacturing Technologies and Skilled Personnel Crucial
    • Strict Regulations Push up Operational Costs
    • Challenges Facing Autologous Cell Therapies
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Regenerative Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Regenerative Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 3: World 16-Year Perspective for Regenerative Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 6: World 16-Year Perspective for Cell Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Gene Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Gene Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 9: World 16-Year Perspective for Gene Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Tissue Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Tissue Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 12: World 16-Year Perspective for Tissue Engineering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 15: World 16-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Biologically Derived by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Biologically Derived by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 18: World 16-Year Perspective for Biologically Derived by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Synthetic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Synthetic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 21: World 16-Year Perspective for Synthetic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Genetically Engineered by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Genetically Engineered by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 24: World 16-Year Perspective for Genetically Engineered by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Other Material Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Other Material Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 27: World 16-Year Perspective for Other Material Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Musculoskeletal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 29: World Historic Review for Musculoskeletal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 30: World 16-Year Perspective for Musculoskeletal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 31: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 32: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 33: World 16-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 34: World Recent Past, Current & Future Analysis for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 35: World Historic Review for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 36: World 16-Year Perspective for Cardiovascular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 37: World Recent Past, Current & Future Analysis for Dermatology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 38: World Historic Review for Dermatology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 39: World 16-Year Perspective for Dermatology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 40: World Recent Past, Current & Future Analysis for Ophthalmology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 41: World Historic Review for Ophthalmology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 42: World 16-Year Perspective for Ophthalmology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 43: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 44: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 45: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
    • TABLE 46: World Regenerative Medicine Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Regenerative Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 47: USA Recent Past, Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 49: USA 16-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2014, 2023 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 52: USA 16-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2014, 2023 & 2030
    • TABLE 53: USA Recent Past, Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 55: USA 16-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 58: Canada 16-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2014, 2023 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 61: Canada 16-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2014, 2023 & 2030
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 64: Canada 16-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2014, 2023 & 2030
  • JAPAN
    • Regenerative Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 67: Japan 16-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2014, 2023 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 70: Japan 16-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2014, 2023 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 73: Japan 16-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2014, 2023 & 2030
  • CHINA
    • Regenerative Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 74: China Recent Past, Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 76: China 16-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2014, 2023 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 79: China 16-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2014, 2023 & 2030
    • TABLE 80: China Recent Past, Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 82: China 16-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2014, 2023 & 2030
  • EUROPE
    • Regenerative Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Regenerative Medicine by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Regenerative Medicine by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Regenerative Medicine by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 88: Europe 16-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2014, 2023 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 91: Europe 16-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2014, 2023 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 94: Europe 16-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2014, 2023 & 2030
  • FRANCE
    • Regenerative Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 95: France Recent Past, Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 97: France 16-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2014, 2023 & 2030
    • TABLE 98: France Recent Past, Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 100: France 16-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2014, 2023 & 2030
    • TABLE 101: France Recent Past, Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 102: France Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 103: France 16-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2014, 2023 & 2030
  • GERMANY
    • Regenerative Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 106: Germany 16-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2014, 2023 & 2030
    • TABLE 107: Germany Recent Past, Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 109: Germany 16-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2014, 2023 & 2030
    • TABLE 110: Germany Recent Past, Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 111: Germany Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 112: Germany 16-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 115: Italy 16-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2014, 2023 & 2030
    • TABLE 116: Italy Recent Past, Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 117: Italy Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 118: Italy 16-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2014, 2023 & 2030
    • TABLE 119: Italy Recent Past, Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 120: Italy Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 121: Italy 16-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • Regenerative Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 122: UK Recent Past, Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 124: UK 16-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2014, 2023 & 2030
    • TABLE 125: UK Recent Past, Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 126: UK Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 127: UK 16-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2014, 2023 & 2030
    • TABLE 128: UK Recent Past, Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 129: UK Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 130: UK 16-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2014, 2023 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 136: Rest of Europe 16-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2014, 2023 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 139: Rest of Europe 16-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • Regenerative Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2014, 2023 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2014, 2023 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2014, 2023 & 2030
  • REST OF WORLD
    • TABLE 149: Rest of World Recent Past, Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 150: Rest of World Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 151: Rest of World 16-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2014, 2023 & 2030
    • TABLE 152: Rest of World Recent Past, Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 153: Rest of World Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 154: Rest of World 16-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2014, 2023 & 2030
    • TABLE 155: Rest of World Recent Past, Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 156: Rest of World Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 157: Rest of World 16-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2014, 2023 & 2030

IV. COMPETITION